 htlv-i/ii seropreval hiv/htlv coinfect intraven drug user data multiyear seropreval survey human t-lymphotrop viru type II htlv-i/ii intraven drug user locat demograph pattern seroposit coinfect human immunodefici viru type seroposit htlv-i/ii whole-viru enzym western blot confirm subject methadon mainten detoxif clinic htlv-i/ii seroposit htlv-i/ii vari racial group age sex geograph locat black age- location-adjust infect rate white seroposit strong gradient age femal rate male adjust age locat locat rate miami baltimor lo angel former rate subject occurr coinfect htlv-i/ii chanc